Your session is about to expire
← Back to Search
HOBSCOTCH Program for Epilepsy
N/A
Recruiting
Led By Barbara Jobst, MD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of epilepsy, with controlled or uncontrolled seizures
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at months 3, 6, 9, 12
Awards & highlights
Study Summary
This trial will test whether HOBSCOTCH, a home-based cognitive self-management program, is effective when delivered virtually using e-health tools.
Who is the study for?
This trial is for adults over 18 with epilepsy who can read and have access to a phone and the internet. They should be on a stable medication regimen for at least one month, although brief stops for specific tests are okay. Participants must also have memory concerns but cannot have dementia, severe mental disability, significant visual impairments, or lack reliable communication tools.Check my eligibility
What is being tested?
The HOBSCOTCH Phase III trial is testing an entirely virtual cognitive self-management program designed to help people with epilepsy manage their condition from home using e-health tools like telephone and computer.See study design
What are the potential side effects?
Since this intervention involves cognitive training and lifestyle management rather than medication, traditional side effects are not expected. However, participants may experience fatigue or stress related to engagement in the program's activities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have epilepsy, with seizures that may or may not be under control.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ ongoing through entire study baseline - 12 months, and at baseline and at months 3, 6, 9, 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ongoing through entire study baseline - 12 months, and at baseline and at months 3, 6, 9, 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in cognitive function
Change in quality of life
Secondary outcome measures
Mental Depression
Change in self-management practices
Changes in health confidence
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: HOBSCOTCH-V (virtual)Experimental Treatment1 Intervention
Participants will receive the HOBSCOTCH intervention consisting of 1:1 sessions delivered once per week, including:
1 pre-HOBSCOTCH Session (on webcam)
1 educational session (on webcam)
6 telephone sessions
1 wrap-up session (webcam or telephone)
Participants will also receive 3 booster sessions, via webcam or telephone, once per month.
Group II: ControlExperimental Treatment1 Intervention
Participants will be wait listed and will receive HOBSCOTCH-V (above) following a 6 month wait period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH)
2015
N/A
~110
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,543,199 Total Patients Enrolled
11 Trials studying Epilepsy
1,010 Patients Enrolled for Epilepsy
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,477,262 Total Patients Enrolled
7 Trials studying Epilepsy
788 Patients Enrolled for Epilepsy
Barbara Jobst, MDPrincipal Investigator - Dartmouth-Hitchcock Medical Center and Dartmouth College
Children's Hospital at Dartmouth, Dartmouth-Hitchcock Medical Center, Mary Hitchcock Memorial Hospital
Friedrich-Alexander-University (Medical School)
Mary Hitchcock Mem Hospital (Residency)
1 Previous Clinical Trials
240 Total Patients Enrolled
1 Trials studying Epilepsy
240 Patients Enrolled for Epilepsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.You need to have access to the internet.You have trouble seeing well enough to read or write.I have access to a telephone.I have never been diagnosed with epilepsy.I feel like my memory is getting worse.I have epilepsy, with seizures that may or may not be under control.I haven't changed my epilepsy or depression meds in the last month.
Research Study Groups:
This trial has the following groups:- Group 1: HOBSCOTCH-V (virtual)
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the participant capacity of this clinical trial?
"Affirmative. According to information from clinicaltrials.gov, this medical research is presently enrolling participants; the trial was initially posted on November 12th 2020 and has undergone a recent update on November 6th 2022. The study requires 130 individuals across 1 site for completion."
Answered by AI
Are there slots remaining for volunteers to join this trial?
"The information published on clinicaltrials.gov ensures that this trial is actively searching for participants; it was initially posted in November 2020 and recently updated mere days ago."
Answered by AI
What are the expected results of this clinical exploration?
"This trial, measured at Baseline and 3, 6, 9 & 12 months from then on will assess Change in cognitive function. Other outcomes are Changes in overall well-being (collected through a smartphone app or paper log with basic Likert-scale of Well-Being); Changes in healthcare utilization (Health Care Utilization 4-item Measure from the Self Management Resource Center capturing services used over the last 6 months) and Change in self management practices (Adult Epilepsy Self Management Measurement Instrument - AESMMI 65; scores ranging between 65 to 325 denoting frequency of usage)."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger